Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

corteva inc. - CTVA

CTVA

Close Chg Chg %
65.32 0.98 1.50%

Closed Market

66.30

+0.98 (1.50%)

Volume: 3.64M

Last Updated:

Dec 4, 2025, 3:59 PM EDT

Trade Now

Company Overview: corteva inc. - CTVA

CTVA Key Data

Open

$65.65

 Day Range

65.64 - 66.45

52 Week Range

53.40 - 77.41

 Market Cap

$44.13B

Shares Outstanding

675.73M

 Public Float

674.75M

Beta

0.74

 Rev. Per Employee

N/A

P/E Ratio

28.01

 EPS

$2.35

Yield

105.18%

 Dividend

$0.18

EX-DIVIDEND DATE

Dec 1, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

3.71M

  

CTVA Performance

1 Week
 
 -1.75%
 
1 Month
 
 3.34%
 
3 Months
 
 -8.31%
 
1 Year
 
 11.43%
 
5 Years
 
 71.51%
 

CTVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 27
Full Ratings ➔

About corteva inc. - CTVA

Corteva, Inc. engages in the provision of seed and crop protection solutions. It focuses on the agriculture industry and food supply. It operates through the Seed and Crop Protection segments. The Seed segment is involved in the development and supply of advanced germplasm and traits that produce yield for farms. The Crop Protection segment includes the global agricultural input industry with products for weeds, insects, other pests, and diseases protection, through nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.

CTVA At a Glance

Corteva, Inc.
9330 Zionsville Road
Indianapolis, Indiana 46268
Phone 1-833-267-8382 Revenue 16.91B
Industry Agricultural Commodities/Milling Net Income 907.00M
Sector Process Industries Employees 22,000
Fiscal Year-end 12 / 2025
View SEC Filings

CTVA Valuation

P/E Current 28.01
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 43.708
Price to Sales Ratio 2.345
Price to Book Ratio 1.642
Price to Cash Flow Ratio 18.48
Enterprise Value to EBITDA 12.016
Enterprise Value to Sales 2.341
Total Debt to Enterprise Value 0.08

CTVA Efficiency

Revenue/Employee 768,545.455
Income Per Employee 41,227.273
Receivables Turnover 2.963
Total Asset Turnover 0.403

CTVA Liquidity

Current Ratio 1.454
Quick Ratio 0.931
Cash Ratio 0.336

CTVA Profitability

Gross Margin 39.419
Operating Margin 12.225
Pretax Margin 7.541
Net Margin 5.364
Return on Assets 2.031
Return on Equity 3.486
Return on Total Capital 3.156
Return on Invested Capital 3.166

CTVA Capital Structure

Total Debt to Total Equity 13.363
Total Debt to Total Capital 11.788
Total Debt to Total Assets 7.787
Long-Term Debt to Equity 9.647
Long-Term Debt to Total Capital 8.51
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Corteva Inc. - CTVA

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
15.65B 17.45B 17.23B 16.91B
Sales Growth
+10.11% +11.50% -1.31% -1.85%
Cost of Goods Sold (COGS) incl D&A
9.92B 11.17B 10.59B 10.24B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.24B 1.22B 1.21B 1.23B
Depreciation
521.00M 521.00M 528.00M 542.00M
Amortization of Intangibles
722.00M 702.00M 683.00M 685.00M
COGS Growth
+7.93% +12.61% -5.20% -3.30%
Gross Income
5.73B 6.28B 6.63B 6.67B
Gross Income Growth
+14.12% +9.58% +5.60% +0.48%
Gross Profit Margin
+36.61% +35.98% +38.51% +39.42%
2021 2022 2023 2024 5-year trend
SG&A Expense
4.40B 4.39B 4.50B 4.59B
Research & Development
1.19B 1.22B 1.34B 1.40B
Other SG&A
3.21B 3.17B 3.16B 3.19B
SGA Growth
+5.04% -0.16% +2.53% +1.93%
Other Operating Expense
- - 13.00M 11.00M
-
Unusual Expense
303.00M 402.00M 382.00M 301.00M
EBIT after Unusual Expense
1.03B 1.49B 1.74B 1.77B
Non Operating Income/Expense
1.34B 15.00M (412.00M) (258.00M)
Non-Operating Interest Income
77.00M 124.00M 283.00M 132.00M
Equity in Earnings of Affiliates
14.00M 20.00M 10.00M 15.00M
Interest Expense
30.00M 79.00M 233.00M 233.00M
Interest Expense Growth
- -33.33% +163.33% +194.94%
Gross Interest Expense
30.00M 79.00M 233.00M 233.00M
Interest Capitalized
- - - -
-
Pretax Income
2.35B 1.43B 1.09B 1.27B
Pretax Income Growth
+247.56% -39.22% -23.35% +16.65%
Pretax Margin
+14.99% +8.17% +6.35% +7.54%
Income Tax
524.00M 210.00M 152.00M 412.00M
Income Tax - Current - Domestic
(7.00M) 86.00M 183.00M 330.00M
Income Tax - Current - Foreign
329.00M 403.00M 407.00M 447.00M
Income Tax - Deferred - Domestic
219.00M (209.00M) (376.00M) (328.00M)
Income Tax - Deferred - Foreign
(17.00M) (70.00M) (62.00M) (37.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
14.00M 20.00M 10.00M 15.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.82B 1.22B 941.00M 863.00M
Minority Interest Expense
10.00M 11.00M 12.00M 12.00M
Net Income
1.81B 1.21B 929.00M 851.00M
Net Income Growth
+146.20% -33.50% -22.90% -8.40%
Net Margin Growth
+11.57% +6.90% +5.39% +5.03%
Extraordinaries & Discontinued Operations
(53.00M) (58.00M) (194.00M) 56.00M
Discontinued Operations
(53.00M) (58.00M) (194.00M) 56.00M
Net Income After Extraordinaries
1.76B 1.15B 735.00M 907.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
1.76B 1.15B 735.00M 907.00M
EPS (Basic)
2.3903 1.5913 1.0367 1.3075
EPS (Basic) Growth
+162.79% -33.43% -34.85% +26.12%
Basic Shares Outstanding
735.90M 720.80M 709.00M 693.70M
EPS (Diluted)
2.3719 1.5832 1.0324 1.3032
EPS (Diluted) Growth
+161.63% -33.25% -34.79% +26.23%
Diluted Shares Outstanding
741.60M 724.50M 711.90M 696.00M
EBITDA
2.58B 3.12B 3.33B 3.29B
EBITDA Growth
+27.99% +20.78% +6.93% -1.11%
EBITDA Margin
+16.47% +17.85% +19.34% +19.48%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 77.143
Number of Ratings 27 Current Quarters Estimate 0.22
FY Report Date 12 / 2025 Current Year's Estimate 3.323
Last Quarter’s Earnings -0.23 Median PE on CY Estimate N/A
Year Ago Earnings 2.57 Next Fiscal Year Estimate 3.665
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 18 10 23 23
Mean Estimate 0.22 1.16 3.32 3.66
High Estimates 0.33 1.24 3.60 3.98
Low Estimate 0.15 1.10 3.15 3.30
Coefficient of Variance 17.86 3.73 2.39 4.61

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 16 16 16
OVERWEIGHT 5 5 5
HOLD 6 6 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Corteva Inc. - CTVA

Date Name Shares Transaction Value
Apr 9, 2025 Audrey Grimm SVP, Chief People Officer 20,677 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $55.79 per share 1,153,569.83
Apr 9, 2025 Robert King EVP, Crop Protection Business 62,220 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $55.79 per share 3,471,253.80
Feb 21, 2025 Sam Eathington See Remarks 63,038 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 4,063,429.48
Feb 21, 2025 Audrey Grimm SVP, Chief People Officer 10,920 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Brian Titus See Remarks 2,730 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Brian Titus See Remarks 16,473 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Brian Titus See Remarks 15,464 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 996,809.44
Feb 21, 2025 David P. Johnson EVP, Chief Financial Officer 18,480 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 David P. Johnson EVP, Chief Financial Officer 64,573 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Sam Eathington See Remarks 13,860 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Sam Eathington See Remarks 68,158 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Charles V. Magro Chief Executive Officer; Director 242,654 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 15,641,476.84
Feb 21, 2025 Judd O'Connor EVP, Seed Business Unit 10,080 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Judd O'Connor EVP, Seed Business Unit 36,977 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Judd O'Connor EVP, Seed Business Unit 33,253 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 2,143,488.38
Feb 21, 2025 Cornel B. Fuerer See Remarks 13,860 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Cornel B. Fuerer See Remarks 140,687 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Cornel B. Fuerer See Remarks 135,567 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $64.46 per share 8,738,648.82
Feb 21, 2025 Charles V. Magro Chief Executive Officer; Director 97,859 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 Charles V. Magro Chief Executive Officer; Director 231,896 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $63.82 per share 14,799,602.72

Corteva Inc. in the News